As prostate cancer cases rise across India, doctors are seeing a growing pattern: more elderly men undergo routine health checkups, receive a Prostate Specific Antigen (PSA) test, and then panic when the number comes back even slightly elevated.
Dr. Gagan Prakash explains that this fear often results from incomplete information and intense online searches. Families quickly discover that a high PSA level can signal prostate cancer, but they rarely learn the equally important fact: not all elevated PSA readings indicate cancer, and not all prostate cancers are dangerous.
Rising Cases, Rising Anxiety
Recent reports show that prostate cancer is increasing sharply in India. National incidence has risen by nearly 30 percent in the past 25 years, and urban regions have seen a rise of up to 80 percent. This trend mirrors Western countries, where prostate cancer is among the most common cancers in men.
At the same time, India’s elderly population is growing. Studies project that by 2050, nearly one-fifth of Indians will be aged 60 and above. As more people age, more men naturally undergo routine health tests — and more PSA results raise alarms.
What Families Often Don’t Know
Here are some common questions, with answers that usually surprise patients:
Is prostate cancer common in older men? Yes.
Is it rising in India? Yes.
Does the PSA test help detect prostate cancer? Yes.
Is every high PSA due to cancer? No.
Is every PSA-detected cancer life-threatening? No.
Does every PSA-detected cancer need treatment? No.
Most families know only the first three answers — the “yes” responses. They almost never hear the three critical “no” answers.
PSA Testing: Helpful but Imperfect
In the 1990s, the West experimented with using PSA tests to screen all men. Many countries later pulled back because mass screening led to overdiagnosis — the detection of cancers so slow-growing that they would never become dangerous.
India has no national policy on routine PSA screening, but increasing access to health packages means more men take the test without understanding what the results mean. An unexpected high value, followed by a quick Google search, often produces panic long before a specialist evaluates the case.
The Truth About Low-Risk Prostate Cancer
Prostate cancer exists on a wide spectrum, from harmless to deadly. Many men diagnosed through routine PSA tests have low-risk or “indolent” cancers. These cancers grow so slowly that patients may live their entire lives without symptoms and without needing treatment.
A major study published in the New England Journal of Medicine followed more than 1,600 men diagnosed with early-stage prostate cancer. Two-thirds received surgery or radiation. One-third received no immediate treatment and were monitored over time.
After 15 years, the study found no significant difference in prostate cancer–related deaths between the treated and untreated groups. Although the monitored group had a slightly higher chance of the cancer spreading, this did not reduce their overall survival because later treatment still worked.
The message is clear: many early-stage prostate cancers do not require urgent treatment.
What Men Should Know
For men diagnosed with early prostate cancer after a routine PSA test, treatment decisions depend on the cancer’s characteristics — not just the PSA number. In many cases, careful monitoring, known as active surveillance, is safer and more appropriate than immediate intervention.
Related topics
